Menu
Menu
90% women
93% graduates
employee turnover ¼ Italian industry
trained staff by external Managers
Qualified by:
AIFA, EMA
EudraVigilance
ENCePP
Debt free Company
Cerved Credibility Member
Private owned company
Customer retention rate 84% in value
Digital clinical trials (inc. e-CRF and e-PRO)
Remote monitoring
Phase I units accreditation
Full statistical services
ISO 9001:2015 certified
SIMEF – GIQAR affiliates
GDPR compliant (independent DPO)
Global Compact Member
We aim to be worldwide the best in class full service CRO specialized in clinical research.
For activities conducted in Italy, HR serves customers in Europe (52%), North America (19%) Japan (9%) and Italy (20%). About 80% of the HR annual revenues come from services regarding clinical research, including regulatory consultancy, conducted in Italy for non-Italian customers.
Total number of customers have been more than doubled in the last 5 years and foreign customers more than quadrupled in the same period. Customer retention rate (2020) of 71% in number of contracts ad 84% in value.HR supports studies in Italy, from first-in-human to phase 4 (around 50% of total revenues).
More than 40% of the total turnover is given by NIS, including PASS and over 10% by medical devices and food supplements.
With 2.000+ clinical sites activated in Italy in various therapeutical areas, HR has a recognized cutting-edge expertise for studies in Cardiology, Onco-haematology, Gastroenterology, Dermatology, Urology, Sexual Health, Neurology, Psychiatry and Infectiology.
HR’s expertise is also recognised in Rare Diseases, Paediatrics and Ophthalmology.
Digital clinical interventional trials on-going with >70% reduction of study visits with physical interaction doctor-patient and >90% of the data efficacy generated and collected remotely.
Remote monitoring Equipment and know-how to perform up-to 90% remote SDV of documents at site.
A broad domestic network of GPs and paediatricians, GCP trained, suitable to carry out interventional phase 3-4 and NIS and food supplement trials. Partnership with Italian Universities in place supporting pre-clinical research activities in gastro-enterology and dermatology.
Digital clinical interventional trials on-going with >70% reduction of study visits with physical interaction doctor-patient and >90% of the data efficacy generated and collected remotely.
Remote monitoring Equipment and know-how to perform up-to 90% remote SDV of documents at site.
A broad domestic network of GPs and paediatricians, GCP trained, suitable to carry out interventional phase 3-4 and NIS and food supplement trials. Partnership with Italian Universities in place supporting pre-clinical research activities in gastro-enterology and dermatology.
